Evolution of cardiorespiratory variables in myxedema coma--a case report

Area of Science:

• Cardiology
• Pulmonology
• Endocrinology

Background:

• Myxedema coma is a severe manifestation of hypothyroidism with high mortality.
• Hemodynamic instability and respiratory failure are common critical complications.

Observation:

• A patient in myxedema coma presented with significant hemodynamic and oxygen transport derangements.
• Initial treatment focused on supportive care and thyroid hormone replacement.

Findings:

• Normalization of hemodynamic, oxygen transport, and oxygen consumption indices was observed within one week of treatment.
• Successful ventilatory weaning and extubation were achieved with aminophylline, physical therapy, and pleural drainage.
• Naloxone administration prior to extubation did not yield significant ventilatory improvement or alter endorphin levels.

Implications:

• This case highlights the potential for rapid recovery of physiological parameters in myxedema coma with appropriate management.
• The combination of therapies proved effective for respiratory weaning, suggesting a multimodal approach is beneficial.
• The lack of response to naloxone warrants further investigation into the role of endogenous opioids in myxedema coma pathophysiology.